ABSTRACT
Psychotic disorders such as schizophrenia are biologically complex and carry huge population morbidity due to their prevalence, persistence and associated disability. Defined by features such as delusions and hallucinations, they involve cognitive dysfunction and neurotransmitter dysregulations that appear mostly to involve the dopaminergic and glutamatergic systems. A number of genetic and environmental factors are associated with these disorders but it has been difficult to identify the biological pathways underlying the principal symptoms. The endophenotype concept of stable, heritable traits that form a mechanistic link between genes and an overt expression of the disorder has potential to reduce the complexity of psychiatric phenotypes. In this study, we used a genetically sensitive design with individuals with a first episode of psychosis, their non-affected first-degree relatives and non-related healthy controls. Metabolomic analysis was combined with neurocognitive assessment to identify multilevel endophenotypic patterns: one concerned reaction times during the performance of cognitive and emotional tests that have previously been associated with the glutamate neurotransmission system, the other involved metabolites involved directly and indirectly in the co-activation of the N-methyl-D-aspartate receptor, a major receptor of the glutamate system. These cognitive and metabolic endophenotypes may comprise a single construct, such that genetically mediated dysfunction in the glutamate system may be responsible for delays in response to cognitive and emotional functions in psychotic disorders. This focus on glutamatergic neurotransmission should guide drug discovery and experimental medicine programmes in schizophrenia and related disorders.
Subject(s)
Endophenotypes/blood , Excitatory Amino Acids/blood , Genetic Predisposition to Disease/genetics , Psychotic Disorders/blood , Psychotic Disorders/genetics , Synaptic Transmission/genetics , Adult , Analysis of Variance , Chromatography, Liquid , Female , Glutamic Acid/blood , Humans , Magnetic Resonance Spectroscopy , Male , Mass Spectrometry , Metabolomics , Neuropsychological Tests , Principal Component Analysis , Psychotic Disorders/physiopathology , Reaction Time , Receptors, N-Methyl-D-Aspartate/blood , Synaptic Transmission/physiology , Young AdultABSTRACT
Bis-(3'-5')-cyclic dimeric guanosine monophosphate (c-di-GMP) is a ubiquitous bacterial signalling molecule produced by diguanylate cyclases of the GGDEF-domain family. Elevated c-di-GMP levels or increased GGDEF protein expression is frequently associated with the onset of sessility and biofilm formation in numerous bacterial species. Conversely, phosphodiesterase-dependent diminution of c-di-GMP levels by EAL- and HD-GYP-domain proteins is often accompanied by increased motility and virulence. In this study, we individually overexpressed 23 predicted GGDEF, EAL or HD-GYP-domain proteins encoded by the phytopathogen Pectobacterium atrosepticum strain SCRI1043. MS-based detection of c-di-GMP and 5'-phosphoguanylyl-(3'-5')-guanosine in these strains revealed that overexpression of most genes promoted modest 1-10-fold changes in cellular levels of c-di-GMP, with the exception of the GGDEF-domain proteins ECA0659 and ECA3374, which induced 1290- and 7660-fold increases, respectively. Overexpression of most EAL domain proteins increased motility, while overexpression of most GGDEF domain proteins reduced motility and increased poly-ß-1,6-N-acetyl-glucosamine-dependent flocculation. In contrast to domain-based predictions, overexpression of the EAL protein ECA3549 or the HD-GYP protein ECA3548 increased c-di-GMP concentrations and reduced motility. Most overexpression constructs altered the levels of secreted cellulases, pectinases and proteases, confirming c-di-GMP regulation of virulence in Pe. atrosepticum. However, there was no apparent correlation between virulence-factor induction and the domain class expressed or cellular c-di-GMP levels, suggesting that regulation was in response to specific effectors within the network, rather than total c-di-GMP concentration. Finally, we demonstrated that the cellular localization patterns vary considerably for GGDEF/EAL/HD-GYP proteins, indicating it is a likely factor restricting specific interactions within the c-di-GMP network.
Subject(s)
Bacterial Proteins/genetics , Cyclic GMP/analogs & derivatives , Gene Expression Regulation, Bacterial , Pectobacterium/genetics , Pectobacterium/physiology , Plant Diseases/microbiology , Signal Transduction , Solanum tuberosum/microbiology , Bacterial Proteins/metabolism , Computational Biology , Cyclic GMP/analysis , Cyclic GMP/metabolism , Gene Expression , Pectobacterium/pathogenicity , Phenotype , Plant Tubers/microbiology , Recombinant Fusion Proteins , VirulenceABSTRACT
The flowers of the ornamental tobacco produce high levels of a series of 6 kDa serine protease inhibitors (NaPIs) that are effective inhibitors of trypsins and chymotrypsins from lepidopteran species. These inhibitors have a negative impact on the growth and development of lepidopteran larvae and have a potential role in plant protection. Here we investigate the effect of NaPIs on the activity and levels of serine proteases in the gut of Helicoverpa armigera larvae and explore the adaptive mechanisms larvae employ to overcome the negative effects of NaPIs in the diet. Polyclonal antibodies were raised against a Helicoverpa punctigera trypsin that is a target for NaPIs and two H. punctigera chymotrypsins; one that is resistant and one that is susceptible to inhibition by NaPIs. The antibodies were used to optimize procedures for extraction of proteases for immunoblot analysis and to assess the effect of NaPIs on the relative levels of the proteases in the gut and frass. We discovered that consumption of NaPIs did not lead to over-production of trypsins or chymotrypsins but did result in excessive loss of proteases to the frass.
Subject(s)
Chymotrypsin/metabolism , Insect Proteins/metabolism , Moths/enzymology , Plant Extracts/metabolism , Solanum tuberosum/chemistry , Trypsin Inhibitors/metabolism , Trypsin/metabolism , Amino Acid Sequence , Animals , Chymotrypsin/antagonists & inhibitors , Chymotrypsin/genetics , Cloning, Molecular , Gastrointestinal Tract/enzymology , Insect Control , Insect Proteins/chemistry , Insect Proteins/genetics , Molecular Sequence Data , Moths/drug effects , Moths/genetics , Moths/metabolism , Plant Extracts/chemistry , Sequence Alignment , Trypsin/chemistry , Trypsin/genetics , Trypsin Inhibitors/chemistryABSTRACT
BACKGROUND: Adequate vitamin D and calcium nutrition play a critical role in the maintenance of musculoskeletal health and are considered the first step in osteoporosis treatment. ROUNDTABLE DISCUSSION: In February 2008 Merck Sharp & Dohme sponsored a 2-day, evidence-based expert panel on the benefits of vitamin D for the patient with osteoporosis and the role of vitamin D in combination with antiresorptive therapy for the management of osteoporosis. One of the primary objectives of the meeting was to review new data on the optimal serum 25-hydroxy vitamin D [25(OH)D] levels. The symposium was attended by 29 researchers and clinicians from Europe and the Middle East. The discussion focused on optimizing vitamin D and calcium nutrition and reducing falls and fractures in osteoporotic patients. CONCLUSIONS: Current evidence and expert opinion suggests that optimal serum 25(OH)D concentrations should be at least 50 nmol/L (20 ng/mL) in all individuals. This implies a population mean close to 75 nmol/L (30 ng/mL). In order to achieve this level, vitamin D intake of at least 20 microg daily is required. There is a wider therapeutic window for vitamin D than previously believed, and doses of 800 IU per day, regardless of sun exposure, season or additional multivitamin use, appear to present little risk of toxicity. Apart from fracture and fall prevention, optimization of vitamin D status may also have additional general health benefits. Based on newly emerging data regarding calcium supplementation, and recommendations for increased vitamin D intake, the current recommendations for calcium intake in postmenopausal women may be unnecessarily high. In addition to vitamin D and calcium, treatment of patients with osteoporosis at high risk of fractures should also include pharmacologic agents with proven vertebral and non-vertebral fracture efficacy.
Subject(s)
Calcium, Dietary/administration & dosage , Osteoporosis/prevention & control , Vitamin D/analogs & derivatives , Vitamin D/administration & dosage , Adult , Aged , Bone Density/drug effects , Calcium, Dietary/blood , Dietary Supplements , Dose-Response Relationship, Drug , Drug Administration Schedule , Drug Therapy, Combination , Evidence-Based Medicine , Female , Fractures, Spontaneous/drug therapy , Fractures, Spontaneous/prevention & control , Humans , Male , Middle Aged , Musculoskeletal System/drug effects , Osteoporosis/drug therapy , Prognosis , Risk Assessment , Sensitivity and Specificity , Severity of Illness Index , Treatment Outcome , Vitamin D/bloodSubject(s)
DNA Mutational Analysis , Marfan Syndrome/genetics , Microfilament Proteins/genetics , Native Hawaiian or Other Pacific Islander/genetics , Adolescent , Adult , Aged , Aorta/pathology , Child , Dilatation, Pathologic , Exons , Female , Fibrillin-1 , Fibrillins , Genetic Counseling , Genetic Predisposition to Disease , Genetic Testing , Humans , Immunohistochemistry , Male , Marfan Syndrome/therapy , Microsatellite Repeats , Middle Aged , Pedigree , Point Mutation , Polymerase Chain ReactionABSTRACT
OBJECTIVES: To compare the response by overweight individuals, counselled in a work environment, to energy-reduced diets in which the amount of sucrose-containing foods is varied. DESIGN: Two energy-reduced diets were designed as a weight-reducing programme. A low-sugar diet (LSD) providing 5% of its energy from sucrose and a sugar-containing diet (SCD) providing 10% of its energy from sucrose incorporated as sweet foods were devised. Both diets were constructed to contain about 33% of the energy from fat. The diets, designed to provide a deficit of 2.51 MJ/day (600 kcal/day) per individual, were randomly allocated to subjects in an 8 week parallel design study. SUBJECTS: Ninety-five subjects were recruited from a large service industry if they were more than 7 kg (1 stone) in weight above body mass index (BMI) 25 kg/m(2). Sixty-eight subjects completed the programme. MEASUREMENTS: Fortnightly body weight measurements were taken using calibrated scales; BMI at baseline and week 8; and nutrient intake using 2 day food record diaries at baseline and weeks 2, 4 and 8. RESULTS: Weight loss over the 8 weeks was 2.2 kg (LSD) and 3.0 kg (SCD). BMI changed from 29.2 on the LSD and 30.1 kg/m(2) SCD at baseline to 28.2 and 28.8 kg/m(2) at week 8 respectively. The actual prescribed commercially added sucrose intakes were 5% energy (LSD) or 10% energy (SCD). Reported percentage energy from fat was significantly lower on the SCD (and would seem to support the theory of an inverse relationship between fat and sugar) than on the LSD, where there was seen to be no significant reduction. There was no evidence of micronutrient dilution that could be directly attributed to the sucrose content of the diets. CONCLUSION: These results provide no justification for the exclusion of added sucrose in weight-reducing diets.
Subject(s)
Dietary Sucrose/administration & dosage , Obesity/diet therapy , Weight Loss , Body Mass Index , Diet Records , Diet, Reducing , Dietary Fats/administration & dosage , Female , Humans , Male , Micronutrients/administration & dosage , Middle AgedABSTRACT
Current OSHA standards for naphthalene exposure are set at 10 ppm (time-weighted average) with a standard threshold exposure concentration of 15 ppm. While several studies have thoroughly delineated the time course and dose response of injury by naphthalene administered ip, the pattern and severity of injury by inhalation exposure are unknown. These studies compare the regiospecific and dose-dependent cytotoxicity of naphthalene after inhalation exposure. Mice and rats were exposed for 4 h to naphthalene vapor at concentrations of 0-110 ppm. In rats, no injury was observed in the lung epithelium at exposure concentrations up to 100 ppm. Exposures as low as 2 ppm produced proximal airway injury in mice, with increased severity in a concentration-dependent fashion up to 75 ppm. Terminal airways of exposed mice exhibited little or no injury at low concentrations (1-3 ppm). Exposures of 8.5 ppm or higher were required to produce injury to Clara cells in the terminal airways. In contrast, administration of naphthalene (=200 mg/kg ip) caused Clara cell cytotoxicity, which was limited to distal airways in mice. Higher doses (>300 mg/kg) extended the injury pattern toward the lobar bronchus. We conclude (1) the pattern of injury to naphthalene is highly dependent on the route of exposure, (2) lung injury to inhaled naphthalene is species dependent, and (3) Clara cells of mouse airways are exquisitely sensitive to inhaled naphthalene at concentrations well below the current OSHA standard for human exposure.
Subject(s)
Lung/drug effects , Naphthalenes/toxicity , Respiratory Mucosa/drug effects , Administration, Inhalation , Air Pollutants/toxicity , Animals , Bronchi/drug effects , Bronchi/pathology , Dose-Response Relationship, Drug , Injections, Intraperitoneal , Lung/pathology , Male , Mice , Naphthalenes/administration & dosage , Rats , Rats, Sprague-Dawley , Respiratory Mucosa/pathologySubject(s)
Disease Management , Heart Failure/therapy , Patient Care Planning/organization & administration , California , Case Management/organization & administration , Evidence-Based Medicine/organization & administration , Female , Heart Failure/diagnosis , Humans , Male , Patient Care Team/organization & administration , Sensitivity and Specificity , Treatment OutcomeABSTRACT
Repeated exposures to Clara cell cytotoxicants, such as naphthalene (NA), render target cell populations resistant to further acute injury. Previous studies suggest that alterations in bioactivation enzymes in target sites (bronchioles) of tolerant mice are insufficient to account for the marked reduction in susceptibility. Mice were made tolerant by seven daily injections of NA. GSH in the terminal airways was 2.7-fold greater in tolerant mice than in vehicle controls and a NA (300 mg/kg) challenge dose did not produce injury. Tolerant mice, allowed to recuperate for 96 h after the seventh NA injection, were again susceptible to NA injury, and terminal airway GSH levels had declined to control levels. To determine whether alterations in GSH resynthesis account for tolerance, the activity of gamma-glutamylcysteine synthetase (gamma-GCS) was measured or mice were treated with a combination of buthionine sulfoximine (BSO), a gamma-GCS inhibitor, and NA. gamma-GCS activity was elevated in resistant airways of tolerant mice. Tolerant mice treated with both BSO and NA appeared as susceptible to injury as NA-challenged controls. We conclude that GSH is critical for Clara cell resistance to NA injury in tolerant mice because: 1) GSH levels in target airways from NA-tolerant animals are elevated; 2) after a 96-h recuperation period, tolerant mice had lower GSH levels and are again susceptible to NA injury; 3) alterations in the activity of gamma-GCS correspond with changes in susceptibility to NA injury; and 4) inhibition of gamma-GCS with BSO increases susceptibility to NA injury in tolerant mice.
Subject(s)
Bronchi/drug effects , Bronchi/metabolism , Glutathione/biosynthesis , Naphthalenes/toxicity , Animals , Bronchi/cytology , Buthionine Sulfoximine/pharmacology , Catalysis , Drug Administration Schedule , Drug Tolerance/physiology , Enzyme Inhibitors/pharmacology , Glutamate-Cysteine Ligase/antagonists & inhibitors , Glutamate-Cysteine Ligase/metabolism , Glutathione/antagonists & inhibitors , Glutathione/physiology , Kinetics , Male , MiceABSTRACT
Clara-cell populations show a high degree of variation in susceptibility to injury by bioactivated cytotoxicants. Because glutathione (GSH) is critical for detoxification of electrophilic metabolites, heterogeneity in Clara cell GSH levels may lead to a wide range of cytotoxic responses. This study was designed to define the distinct GSH pools within Clara cells, characterize heterogeneity within the population, and examine whether heterogeneity contributes to susceptibility. Using fluorescent imaging combined with high-performance liquid chromatography analysis, semiquantitative measurements were obtained by evaluation of GSH using monochlorobimane and monobromobimane. In steady-state conditions, the GSH measured in isolated cells was in the femtomole range, but varied 4-fold between individual cells. Clara cells analyzed in situ and in vitro confirmed this heterogeneity. The response of these cells to compounds that modulate GSH was also variable. Diethylmaleate depleted GSH, whereas GSH monoethylester augmented it. However, both acted nonuniformly in isolated Clara cells. The depletion of intracellular GSH caused a striking decrease in cell viability upon incubation with naphthalene (NA). The sulfhydryl-binding fluorochrome BODIPY, which colocalized with tetramethylrosamine, a mitochondrial dye, demonstrated by confocal microscopy that cellular sulfhydryls are highest in the mitochondria, next-highest in cytoplasm, and lowest in the nucleus. These pools responded differently to modulators of GSH. We concluded that the steady-state intracellular GSH of Clara cells exists in distinct pools and is highly heterogeneous within the population, and that the heterogeneity of GSH levels corresponds closely to the response of Clara cells to injury by NA.
Subject(s)
Cytotoxins/toxicity , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Glutathione/metabolism , Lung/cytology , Lung/drug effects , Acetylcysteine/metabolism , Animals , Boron Compounds , Bridged Bicyclo Compounds, Heterocyclic/metabolism , Cell Nucleus/drug effects , Cell Nucleus/metabolism , Cell Survival/drug effects , Cells, Cultured , Chromatography, High Pressure Liquid , Cytoplasm/drug effects , Cytoplasm/metabolism , Epithelial Cells/cytology , Fluorescent Dyes , Glutathione/analogs & derivatives , Maleates/metabolism , Microscopy, Fluorescence , Mitochondria/drug effects , Mitochondria/metabolism , Naphthalenes/toxicityABSTRACT
Chronic heart failure (CHF) is a highly prevalent condition associated with serious morbidity, intense levels of health services use, and shortened survival. It is also a condition for which ameliorative therapies exist. The evidence indicates that there is substantial need to change clinical practice and health care delivery for people with CHF and thereby improve their outcomes. The goal of the Veterans Affairs (VA) Quality Enhancement Research Initiative in CHF (CHF QUERI) is to create measurable, rapid, and sustainable improvements in quality of care and health outcomes of veterans with heart failure. This article describes the current state of knowledge and practice in care for people with CHF. Using the framework of the 5 steps of the QUERI process, we point out the gaps in research and practice that must be filled if the CHF QUERI is to achieve its goal. We relate our recommendations for how the VA can put its research and administrative infrastructure to work to fill the gaps. Lessons learned about CHF in the course of the CHF QUERI will be applicable to all people with heart failure and to all health care systems--VA as well as non-VA--that care for them.
Subject(s)
Health Services Research/organization & administration , Heart Failure/therapy , Total Quality Management/organization & administration , United States Department of Veterans Affairs/organization & administration , Benchmarking/organization & administration , Chronic Disease , Documentation/methods , Documentation/standards , Evidence-Based Medicine , Heart Failure/mortality , Heart Failure/psychology , Humans , Morbidity , Outcome and Process Assessment, Health Care/organization & administration , Quality of Life , Survival Analysis , United States/epidemiologyABSTRACT
The treatment of chronic disease is often complicated by the coexistence of multiple medical conditions and by the presence of social and psychological impediments. The needs posed by patients with chronic disease are overwhelming the capacity of the American health care system. Alternative disease management systems that rely on specially trained nurse case managers to implement detailed clinical protocols, including drug algorithms, have shown efficacy in managing chronic medical conditions, singly and in combination. By fostering integration of care across subspecialty and medical-social boundaries, such systems enable treatment of the patient with disease(s), not simply treatment of disease(s) in the patient. Working closely with primary care physicians, often by telephone-mediated interaction with patients, nurse case managers may take an expanded role in meeting the challenges posed by chronic disease.
Subject(s)
Case Management , Chronic Disease , Delivery of Health Care , Primary Health Care , Chronic Disease/nursing , Humans , Morbidity , United StatesABSTRACT
Intraspecific studies of red algae have relied on nuclear or plastid markers rather than mitochondrial data to address questions of systematics, biogeography or population genetics. In this study, primers were developed that spanned the noncoding intergenic region between the mitochondrial cytochrome oxidase subunit 2 and cytochrome oxidase subunit 3 genes. These primers were demonstrated to be successful on a variety of red algae in different orders: Gracilariales, Bonnemaisoniales and Ceramiales (families: Delesseriaceae, Ceramiaceae and Rhodomelaceae). Amplification products were between 450 and 320 bp in length, with variation in length shown among geographically distant isolates within a species. The region was variable within a single species, as shown for Bostrychia moritziana and B. radicans, and within populations of Caloglossa leprieurii. In the latter species, four mitochondrial haplotypes were observed in isolates from a single locality in Woolooware Bay, New South Wales, Australia. Analysis of hybrids between different mitochondrial haplotypes of B. moritziana revealed that the mitochondria are maternally inherited in this species. This is the first report of a mitochondrial marker that is variable within red algal populations and may lead to a better understanding of the population ecology of these important marine organisms.
Subject(s)
DNA, Mitochondrial/genetics , Genetic Markers , Rhodophyta/genetics , Base Sequence , Electron Transport Complex IV/genetics , Molecular Sequence Data , Rhodophyta/classification , Sequence Analysis, DNAABSTRACT
We developed a sensitive polymerase chain reaction (PCR) panel, suitable for the detection of seven common respiratory viruses, to study the prevalence of viruses in nasal swabs obtained from clinically stable asthmatic children (n = 21), non-physician diagnosed asthmatic children with exercise-induced bronchoconstriction (EIB) (n = 16), and nonasthmatic, non-EIB controls (n = 33). The PCR panel detected viruses in 43/70 (61.4%) specimens but there were no significant differences in prevalence of these viruses between the three groups of children. These results indicate that clinically stable asthmatic and nonasthmatic children frequently harbor viruses in the upper respiratory tract.
Subject(s)
Asthma/virology , Nose/virology , Polymerase Chain Reaction/methods , Viruses/isolation & purification , Adenoviruses, Human/isolation & purification , Asthma/complications , Child , Coronavirus/isolation & purification , DNA, Viral/analysis , Female , Humans , Influenza A virus/isolation & purification , Male , Picornaviridae/isolation & purification , RNA, Viral/analysis , Respiratory Syncytial Virus, Human/isolation & purification , Respirovirus/isolation & purification , Sensitivity and SpecificityABSTRACT
PURPOSE: Cataract surgery in the presence of active proliferative diabetic eye disease carries a high risk of progression of retinopathy and neovascular glaucoma. Lens opacities may prevent panretinal photocoagulation (PRP) before surgery, and applying PRP in the immediate post-operative period can be difficult. The purpose of this study is to report results of cataract extraction combined with per-operative indirect laser PRP in a group of these patients. METHODS: Nine eyes of 9 diabetic patients with active retinal or iris neovascularisation in which lens opacities prevented adequate pre-operative PRP underwent cataract surgery combined with indirect laser PRP after cortex aspiration and before intraocular lens implantation. RESULTS: Regression of neovascularisation with this combined procedure alone was achieved in 5 eyes, 3 responded to further PRP, and 1 developed neovascular glaucoma. Visual acuity improved in all eyes, 4 achieving > or = 6/12. Four patients developed increased post-operative uveitis. One developed clinically significant macular oedema. CONCLUSIONS: The method described has definite practical advantages over PRP attempted in the immediate post-operative period, when many factors can prevent its application or reduce its effectiveness, and when neovascularisation may be progressing rapidly. In addition, adjunctive per-operative indirect laser PRP appears to improve the outcome of cataract surgery in eyes with active proliferative diabetic eye disease.
Subject(s)
Cataract Extraction , Diabetic Retinopathy/surgery , Laser Coagulation/methods , Retinal Neovascularization/surgery , Adult , Aged , Aged, 80 and over , Cataract Extraction/adverse effects , Diabetic Retinopathy/physiopathology , Female , Follow-Up Studies , Humans , Laser Coagulation/adverse effects , Male , Middle Aged , Retinal Neovascularization/physiopathology , Treatment Outcome , Uveitis/etiology , Visual AcuitySubject(s)
Case Management , Diabetes Mellitus/nursing , Diabetes Complications , Humans , Patient ComplianceABSTRACT
OBJECTIVES: To determine whether psychological distress differs among individuals tested for a BRCA1 mutation and is moderated by the pattern of their siblings' test results. MATERIALS AND METHODS: Participants in this study are members of a large kindred identified with a BRCA1 mutation. Subjects included 87 males and 125 females who completed a baseline interview, were tested for a BRCA1 gene mutation, received their results in person from a genetic counselor, completed a follow-up interview 1-2 weeks after the receipt of their test results, and had complete data on all variables used in the analysis. The main outcome of the study was psychological distress as measured by the Impact of Event Scale during the 1-2 week follow-up interview. Data were analyzed based on multiple regression. RESULTS: Male carriers, relative to noncarriers, experienced significantly more distress if they were the first tested than when all of their tested siblings were already known to be negative. Noncarrier males whose siblings all tested positive also encountered significant test-related distress. The largest adverse psychological consequences for female carriers, relative to noncarriers, were for those who were tested first and those whose tested siblings were noncarriers. CONCLUSIONS: The familial context in which genetic testing is conducted may be important for understanding how individuals react to their own test results.
Subject(s)
Attitude to Health , Family/psychology , Genes, BRCA1/genetics , Genetic Carrier Screening , Genetic Predisposition to Disease/genetics , Genetic Testing/psychology , Mutation/genetics , Stress, Psychological/psychology , Adult , Female , Follow-Up Studies , Guilt , Humans , Least-Squares Analysis , Male , Surveys and Questionnaires , Time FactorsABSTRACT
Analysis of the genetic changes in human tumors is often problematical because of the presence of normal stroma and the limited availability of pure tumor DNA. However, large amounts of highly reproducible "representations" of tumor and normal genomes can be made by PCR from nanogram amounts of restriction endonuclease cleaved DNA that has been ligated to oligonucleotide adaptors. We show here that representations are useful for many types of genetic analyses, including measuring relative gene copy number, loss of heterozygosity, and comparative genomic hybridization. Representations may be prepared even from sorted nuclei from fixed and archived tumor biopsies.
Subject(s)
Chromosome Deletion , DNA, Neoplasm/genetics , Genes, Tumor Suppressor , Genome, Human , Neoplasms/genetics , Blotting, Southern , Chromosome Mapping , DNA/genetics , Female , Genes, erbB-2 , Genetic Carrier Screening , Humans , Neoplasms/pathology , Placenta , Polymerase Chain Reaction/methods , Pregnancy , Restriction MappingABSTRACT
OBJECTIVE: To demonstrate that an agreement approach to applying equations on the basis of clinical and exercise test variables is an accurate, self-calibrating, and cost-efficient method for predicting severe coronary artery disease in clinical populations. DESIGN: Retrospective analysis of consecutive patients with complete data from exercise testing and coronary angiography referred for evaluation of possible coronary artery disease. After developing an equation in a training set, this equation and two other equations developed by other investigators were validated in a test set. The study was performed at two university-affiliated Veteran's Affairs medical centers. PATIENTS: 1080 consecutive men studied between 1985 and 1995 who had coronary angiography within 3 months of the treadmill test. The population was randomly divided into a training set of 701 patients and a test set of 379 patients. Patients with previous coronary artery bypass surgery, valvular heart disease, marked degrees of resting ST depression, and left bundle branch block were excluded. MEASUREMENTS: Recording of clinical and exercise test data along with visual interpretation of the electrocardiogram recordings on standardized forms and abstraction of visually interpreted angiographic data from clinical catheterization reports. RESULTS: Simple clinical and exercise test variables improved the standard application of exercise-induced ST criteria for predicting severe coronary artery disease. By setting probability thresholds for severe disease of <20% and >40% for the three prediction equations, the agreement approach divided the test set into three groups: low risk (patients with all three equations predicting <21% probability of severe coronary disease), no agreement, and high risk (all three equations with >39% probability) for severe coronary artery disease. Because the patients in the no agreement group would be sent for further testing and would eventually be correctly classified, the sensitivity of the agreement approach was 89% and the specificity was 96%. The agreement approach appeared to be unaffected by disease prevalence, missing data, variable definitions, or even angiographic criteria. CONCLUSIONS: Requiring diagnosis of severe coronary disease to be dependent on agreement between these three equations has made them likely to function in all clinical populations. The agreement approach should be an efficient method for the evaluation of populations with varying prevalence of coronary artery disease, limiting the use of more expensive noninvasive and invasive testing to patients with a higher probability of left main or triple-vessel coronary artery disease. This approach provides a strategy that can be applied by inputting the results of basic clinical assessment into a programmable calculator or a computer to assist the practitioner in deciding when further evaluation is appropriate, thus assuring patients access to subspecialty care.
Subject(s)
Coronary Angiography , Coronary Disease/diagnosis , Exercise Test , Confounding Factors, Epidemiologic , Coronary Disease/diagnostic imaging , Coronary Disease/physiopathology , Electrocardiography , Humans , Male , Predictive Value of Tests , ROC Curve , Reproducibility of Results , Retrospective Studies , Risk , Severity of Illness IndexABSTRACT
OBJECTIVE: To demonstrate that a consensus approach for combining prediction equations based on clinical and exercise test variables derived from different populations can stratify patients referred for possible coronary artery disease (CAD) into low-, intermediate-, and high-risk groups. DESIGN: Retrospective analysis of consecutive patients with complete data from exercise testing and coronary angiography referred for evaluation of possible CAD. After derivation of a logistic equation in our own training set of patients, this equation, along with two other equations developed independently by other investigators, was validated in a test set. The validation strategy for the consensus approach included the following: (1) calculation of probability scores for each patient using each logistic equation independently; (2) determination of probability thresholds in the training set to divide the patients into three groups-low risk (prevalence CAD <5%), intermediate risk (5 to 70%), and high risk (>70% prevalence of CAD); (3) using agreement among at least two of three of the prediction equations to generate "consensus" for each patient; and (4) application of the consensus approach thresholds to the test set of patients. SETTINGS: Two university-affiliated Veteran's Affairs medical centers. PATIENTS: We studied 718 consecutive men between 1985 and 1995 who had coronary angiography within 3 months of an exercise treadmill test for suspected CAD. The population was randomly divided into a training set of 429 patients and a test set of 289 patients. Patients with previous myocardial infarction or coronary artery bypass surgery, valvular heart disease, left bundle branch block, or any Q waves present on their resting ECG were excluded from the study. MEASUREMENTS: Recording of clinical and exercise test data along with visual interpretation of the ECG recordings on standardized forms and abstraction of visually interpreted angiographic data from clinical catheterization reports. RESULTS: We demonstrated that by using simple clinical and exercise test variables, we could improve on the standard use of ECG criteria during exercise testing for diagnosing CAD. Using the consensus approach divided the test set into populations with low, intermediate, and high risk for CAD. Since the patients in the intermediate group would be sent for further testing and would eventually be correctly classified, the sensitivity of the consensus approach is 94% and the specificity is 92%. The consensus approach controls for varying disease prevalence, missing data, inconsistency in variable definition, and varying angiographic criterion for stenosis severity. The percent of correct diagnoses increased from the 67% for standard exercise ECG analysis and from the 80% for multivariable predictive equations alone to >90% correct diagnoses for the consensus approach. CONCLUSIONS: The consensus approach has made population-specific logistic regression equations portable to other populations. Excellent diagnostic characteristics can be obtained using simple data and measurements. The consensus approach is best applied utilizing a programmable calculator or a computer program to simplify the process of calculating the probability of CAD using the three equations.